These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1026538)

  • 1. Disopyramide in patients with ventricular premature beats: an experimental model and preliminary results.
    Hohansson BW; Persson S
    J Int Med Res; 1976; 4(1 Suppl):96-9. PubMed ID: 1026538
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-arrhythmic and haemodynamic effects of intravenous and oral disopyramide in patients with ventricular arrhythmia.
    Hulting J; Rosenhamer G
    J Int Med Res; 1976; 4(1 Suppl):90-5. PubMed ID: 1026537
    [No Abstract]   [Full Text] [Related]  

  • 3. Ventricular tachycardia-flutter associated with disopyramide therapy: a report of three cases.
    Dhurandhar RW; Nademanee K; Goldman AM
    Heart Lung; 1978; 7(5):783-7. PubMed ID: 250503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico assessment of the effects of quinidine, disopyramide and E-4031 on short QT syndrome variant 1 in the human ventricles.
    Luo C; Wang K; Zhang H
    PLoS One; 2017; 12(6):e0179515. PubMed ID: 28632743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The electrophysiology of Norpace (Part II).
    Befeler B
    Angiology; 1975 Jan; 26(1 Pt 2):116-9. PubMed ID: 1115398
    [No Abstract]   [Full Text] [Related]  

  • 6. [Electrophysiological effects of disopyramide on the specialized cardiac conduction system in man (author's transl)].
    Hombach V; Hespe I; Gil-Sanchez D; Freyland MD; Behrenbeck DW; Krüger H; Tauchert M; Hilger HH
    Z Kardiol; 1978 Aug; 67(8):527-33. PubMed ID: 695804
    [No Abstract]   [Full Text] [Related]  

  • 7. Modelling the effects of quinidine, disopyramide, and E-4031 on short QT syndrome variant 3 in the human ventricles.
    Luo C; Wang K; Zhang H
    Physiol Meas; 2017 Sep; 38(10):1859-1873. PubMed ID: 28812984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Torsade de pointes ventricular tachycardia. A complication of disopyramide shared with quinidine.
    Wald RW; Waxman MB; Colman JM
    J Electrocardiol; 1981 Jul; 14(3):301-7. PubMed ID: 7264507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the efficacy of propafenone versus disopyramide for complex premature ventricular contractions. Evaluation with long-term monitoring.
    Naccarella F; Palmieri M; del Corso P; Lombardi G; Bracchetti D
    Arzneimittelforschung; 1982; 32(5):547-50. PubMed ID: 7201833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative comparison of the anticholinergic and antiarrhytmic actions of disopyramide and quinidine.
    Pérez A; Ledea N; Hermández K; Garcia-Barreto D
    Pol J Pharmacol Pharm; 1977; 29(5):527-32. PubMed ID: 593967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study of quinidine and disopyramide in the treatment of stable ventricular extrasystole].
    Barnay C; Medvedowsky JL; Clémenty J; Bricaud H; Pellet J; Denis B; Machecourt J; Wolf JE; Dimitrio R; Egre A
    Arch Mal Coeur Vaiss; 1983 Aug; 76(8):909-17. PubMed ID: 6194768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of ventricular tachyarrhythmia with disopyramid phosphate].
    Steinbrunn W; Mattmann H; Enrico JF; Engel U
    Schweiz Med Wochenschr; 1980 Jun; 110(24):953-7. PubMed ID: 7414314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of disopyramide on the atrio-ventricular conduction in man. Preliminary results in 13 cases studied by means of recording bundle of His].
    Lotto A; Graziina A; Rota M; Cavallaro GF; Greco EM
    Boll Soc Ital Cardiol; 1973; 18(10):934-6. PubMed ID: 4807027
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of quinidine and disopyramide on serum digoxin concentrations.
    Manolas EG; Hunt D; Sloman G
    Aust N Z J Med; 1980 Aug; 10(4):426-9. PubMed ID: 6932834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of disopyramide phosphate in extrasystole at rest and on exercise (author's transl)].
    Stauch M; Grewe N; Nissen H
    MMW Munch Med Wochenschr; 1976 Mar; 118(11):331-4. PubMed ID: 57570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disopyramide-induced ventricular tachycardia.
    Lo KS; Gantz KB; Stetson PL; Lucchesi BR; Pitt B
    Arch Intern Med; 1980 Mar; 140(3):413-4. PubMed ID: 6153888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Holter monitoring comparative assessment of propafenone and dihydroquinidine efficacy in the treatment of premature ventricular beats.
    Rizzon P; De Toma L; Mangini SG; Scrutinio D; Lagioia R; De Nicolò M
    Cardiologia; 1983 Sep; 28(9):791-801. PubMed ID: 6398703
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical pharmacology of the antiarrhythmic agent disopyramide phosphate (Norpace).
    Befeler B; Lazzara R
    Heart Lung; 1980; 9(3):475-82. PubMed ID: 6901520
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of oral disopyramide therapy on left ventricular function.
    Greene AC; Iskandrian AS; Hakki AH; Kane SA; Segal BL
    Chest; 1983 Mar; 83(3):480-4. PubMed ID: 6825481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intravenously disopyramide phosphate administration for treatment of arrhythmias].
    Aquaro G; Belli R; Pavia M; Rey L; Ravera A; Possavino G; Idone P
    G Ital Cardiol; 1982; 12(7):509-19. PubMed ID: 7169147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.